Zomedica Pharmaceuticals Corp Stock Widgets and Gadgets
| ZOM Stock | USD 0.12 0 2.50% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ZOM Zomedica Pharmaceuticals Corp
- Latest Are You Missing Out On This NASDAQ-Listed Weed Stock Low-Cost Model Meets European Demand
- ZOM 0.12 0.003
- Low 0.12
- High 0.12
- Alpha -0.12
- Beta 0.59
- Return On Equity -0.24
- Return On Asset -0.0929
- Profit Margin (2.15) %
- Operating Margin (1.48) %
- Current Valuation 47.11 M
- Shares Outstanding 997.95 M
- Shares Owned By Insiders 1.70 %
- Shares Owned By Institutions 8.33 %
- Number Of Shares Shorted 51.14 M
- Price To Book 0.60 X
- Price To Sales 4.67 X
- Revenue 25.19 M
- Gross Profit 13.65 M
- EBITDA (29.39 M)
- Net Income (34.53 M)
- Cash And Equivalents 27.4 M
- Cash Per Share 0.19 X
- Total Debt 2.73 M
- Debt To Equity 0.01 %
- Current Ratio 43.50 X
- Book Value Per Share 0.24 X
- Cash Flow From Operations (15.97 M)
- Short Ratio 17.24 X
- Earnings Per Share (0.06) X
- Target Price 0.25
- Number Of Employees 144
- Beta 1.06
- Market Capitalization 147.6 M
- Total Asset 253.2 M
- Retained Earnings (170.93 M)
- Working Capital 90.85 M
- Net Asset 253.2 M
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.03
- Day Median Price 0.12
- Day Typical Price 0.12
- Price Action Indicator 0.0045
- Period Momentum Indicator 0.003
- Relative Strength Index 51.66
Market Snapshot Widget Example
DAX Index Germany | 20,426 0.13 | |
Taiwan Weighted Taiwan | 23,047 0.63 | |
PSI 20 Stock Portugal | 6,361 0.14 | |
CROBEX Croatia | 3,190 0.53 | |
Budapest SE Hungary | 80,540 0.01 | |
IDX 30 Jakarta Indonesia | 448.05 1.98 | |
ISEQ 20 Price Ireland | 1,648 0.39 | |
NYSE Comp USA | 19,769 0.61 | |
Tel Aviv 35 Israel | 2,335 0.04 | |
Coreshares Index Tracker South Afric | 1,084 0.28 | |
IPC MEXICO Mexico | 51,296 0.01 | |
KL Technology Malaysia | 62.34 0.1 | |
IBEX 35 Index Spain | 11,765 0.21 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,638 0.30 | |
SPASX Dividend Opportunities Australia | 1,688 0.43 | |
HNX 30 Vietnam | 485.48 0.81 | |
Bucharest BET-NG Romania | 1,247 1.10 | |
AMS Small Cap Netherlands | 1,242 0.75 | |
Oslo Exchange Mutual Norway | 1,407 0.21 | |
BEL Small Belgium | 8,052 0.28 | |
Basic Materials Brazil | 5,895 2.11 | |
Swiss Leader Price Switzerland | 1,941 0.25 | |
Fondo Mutuo ETF Chile | 1,404 0.67 | |
Athens General Comp Greece | 1,464 0.44 | |
Stock Exchange Of Thailand | 1,440 0.22 | |
PX Prague Stock Czech Repub | 1,722 0.02 | |
THE PHILIPPINE STOCK Philippines | 6,641 0.02 | |
WIG 30 Poland | 2,900 0.81 | |
BIST Electricity Turkey | 510.98 0.62 |
Investing Ideas
In addition to having Zomedica Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Zomedica Pharmaceuticals
Compare Zomedica Pharmaceuticals To Peers
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zomedica Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share 0.027 | Quarterly Revenue Growth 0.018 | Return On Assets (0.09) | Return On Equity (0.24) |
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.